BACKGROUND: Bipolar disorder is associated with excess cardiovascular mortality. We hypothesized outpatients with bipolar disorder would exhibit excess cardiovascular risk factors, particularly among prevalent users of the second-generation antipsychotics associated with weight gain and valproic acid derivatives. METHODS: This chart review of 217 patients with bipolar disorder examined cardiovascular risk factors of the metabolic syndrome. We also evaluated if certain medications were cross-sectionally associated with metabolic syndrome. RESULTS: Fifty-six patients were not weighed and many did not have available lipid profiles. Over three-quarters of those with available data (n = 161) were overweight or obese (body mass index >or= 25) and nearly half were obese (body mass index >or= 30). A prevalence exceeding general population estimates was also observed for hypertriglyceridemia, elevated blood pressure/hypertension, and elevated fasting glucose/diabetes. Among those with all requisite data (n = 60), over 50% met criteria for National Cholesterol Education Program-defined metabolic syndrome, nearly double the expected prevalence. A trend toward greater prevalence of metabolic syndrome among prevalent users of the second-generation antipsychotics associated with weight gain was observed. CONCLUSIONS: Obesity and the metabolic syndrome were common in patients with bipolar disorder. These patients may be under-evaluated for cardiovascular risk and warrant screening and early intervention.
BACKGROUND:Bipolar disorder is associated with excess cardiovascular mortality. We hypothesized outpatients with bipolar disorder would exhibit excess cardiovascular risk factors, particularly among prevalent users of the second-generation antipsychotics associated with weight gain and valproic acid derivatives. METHODS: This chart review of 217 patients with bipolar disorder examined cardiovascular risk factors of the metabolic syndrome. We also evaluated if certain medications were cross-sectionally associated with metabolic syndrome. RESULTS: Fifty-six patients were not weighed and many did not have available lipid profiles. Over three-quarters of those with available data (n = 161) were overweight or obese (body mass index >or= 25) and nearly half were obese (body mass index >or= 30). A prevalence exceeding general population estimates was also observed for hypertriglyceridemia, elevated blood pressure/hypertension, and elevated fasting glucose/diabetes. Among those with all requisite data (n = 60), over 50% met criteria for National Cholesterol Education Program-defined metabolic syndrome, nearly double the expected prevalence. A trend toward greater prevalence of metabolic syndrome among prevalent users of the second-generation antipsychotics associated with weight gain was observed. CONCLUSIONS:Obesity and the metabolic syndrome were common in patients with bipolar disorder. These patients may be under-evaluated for cardiovascular risk and warrant screening and early intervention.
Authors: Gregory E Simon; Michael Von Korff; Kathleen Saunders; Diana L Miglioretti; Paul K Crane; Gerald van Belle; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2006-07
Authors: Ellen M Weissman; Carolyn W Zhu; Nina R Schooler; Raymond R Goetz; Susan M Essock Journal: J Clin Psychiatry Date: 2006-09 Impact factor: 4.384
Authors: Julie Kreyenbuhl; Faith B Dickerson; Deborah R Medoff; Clayton H Brown; Richard W Goldberg; Lijuan Fang; Karen Wohlheiter; Leena P Mittal; Lisa B Dixon Journal: J Nerv Ment Dis Date: 2006-06 Impact factor: 2.254
Authors: Jeff J Guo; Paul E Keck; Patricia K Corey-Lisle; Hong Li; Dongming Jiang; Raymond Jang; Gilbert J L'Italien Journal: J Clin Psychiatry Date: 2006-07 Impact factor: 4.384
Authors: Astrid B Birkenaes; Stein Opjordsmoen; Cathrine Brunborg; John A Engh; Halldora Jonsdottir; P Andreas Ringen; Carmen Simonsen; Anja Vaskinn; Kåre I Birkeland; Svein Friis; Kjetil Sundet; Ole A Andreassen Journal: J Clin Psychiatry Date: 2007-06 Impact factor: 4.384
Authors: Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein Journal: J Clin Psychiatry Date: 2019-07-30 Impact factor: 4.384
Authors: Jess G Fiedorowicz; David A Solomon; Jean Endicott; Andrew C Leon; Chunshan Li; John P Rice; William H Coryell Journal: Psychosom Med Date: 2009-06-26 Impact factor: 4.312
Authors: Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer Journal: Bipolar Disord Date: 2014-12-12 Impact factor: 6.744